@article{GÜNEŞ2021_508839,
author={Ahmet Kürşad GÜNEŞ and Vildan ÖZKOCAMAZ and Olga Meltem AKAY and Şehmus ERTOP and Birsen SAHİP and Burhan Ferhanoğlu and DEMET ÇEKDEMIR and Vahap OKAN and EMEL GURKAN and İrfan YAVAŞOĞLU and Hüseyin Derya Dinçyürek and Salih Sertaç DURUSOY and MEHMET YILMAZ and Aydan AKDENİZ and Funda Pepedil TANRIKULU and Alperen KIZIKLI and Nilgün Sayınalp and ANIL TOMBAK and Derya SELİM BATUR and Abdülkadir BAŞTÜRK and BURAK deveci and Özgür MEHTAP and Güven Çetin and MEHMET ALİ ÖZCAN and Elif Gülsüm ÜMİT and Emin KAYA and Hatice Terzi and Mehmet Hilmi DOĞU and Rahşan YILDIRIM and Ahmet SEYHANLI and Sinan Demircioğlu and Ali ÜNAL and Ömer ÖZCAN and Güray SAYDAM and EREN ARSLAN DAVULCU and ISMET AYDOGDU and Mehmet Ali UÇAR and Müfide OKAY and GÜL ILHAN},
title={Efficacy and Safety of Ibrutinib Therapy in Patients with Chronic
Lymphocytic Leukemia: Retrospective Analysis of Real-Life Data},
year={2021},
journal={Turkish Journal of Hematology},
issn={1300-7777},
volume={38},
number={4},
url={http://search/yayin/detay/508839}
}